Mounjaro and an Increased Heart Rate: How to Decide What to Do Next

A raised resting heart rate has been recorded in tirzepatide trials and is listed in the official Mounjaro prescribing information as a known, generally mild effect.
The increase is usually small (often under 5 bpm) and tends to be most noticeable after starting treatment or stepping up a dose.
Palpitations, racing pulse or a pounding sensation that feels severe or persists beyond the first couple of weeks warrants prompt medical advice, not watchful waiting.
Dehydration from nausea, vomiting or diarrhoea can independently raise heart rate — staying well-hydrated on treatment matters.

A faster-than-usual heart rate is a recognised side effect of tirzepatide (Mounjaro). Clinical trial data and the medicine's SmPC both document a modest rise in resting heart rate in some people, typically a small increase of around a few beats per minute. For most people it is mild and settles, but knowing when to act on it matters. Mounjaro is a prescription-only medicine; any concerns about how your heart is responding should go to your prescribing clinician, not to a forum.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding the heart-rate effect of Mounjaro and making the right call for your health

Why does tirzepatide affect heart rate at all?

The GIP and GLP-1 receptors that tirzepatide activates are found not just in the gut and brain but in cardiac tissue too. Stimulating these receptors appears to produce a small chronotropic effect (meaning the heart beats slightly faster) in some people. This is not unique to Mounjaro; a similar pattern is seen across the broader GLP-1 medicine class. The Mounjaro overview explains the dual-receptor mechanism in more detail if you want the background on how tirzepatide works.

Importantly, this is distinct from a dangerous arrhythmia. What most people notice (if they notice anything) is a pulse that sits a handful of beats per minute above their usual baseline. That said, individual responses vary considerably, and a rise that is trivial for one person can feel very noticeable for another, particularly anyone who is sensitive to physical symptoms or who is monitoring closely with a smartwatch. For a deeper look at the proposed mechanism behind this specific effect, our page on why Mounjaro raises heart rate covers the physiology in full.

Dehydration deserves a mention here too. Nausea and vomiting, which are among the most common early side effects of tirzepatide, can reduce fluid intake and push heart rate up independently of anything the medicine itself is doing to cardiac receptors. If your pulse feels elevated and you have also been struggling with GI symptoms, rehydration is the first practical step, and then reassess. The NHS's patient guidance on tirzepatide side effects is worth reading alongside the leaflet that came with your pen.

The real decision: watch, wait, or contact someone now?

This is the question most people are actually asking when they search this topic. The honest answer has two parts.

For a mildly elevated resting heart rate with no other symptoms, the usual clinical approach is to give it time, particularly in the first two to four weeks of a new dose. The effect often settles as your body adjusts. Staying hydrated, avoiding large quantities of caffeine, and keeping your prescriber in the loop at your next review is generally appropriate. If you are on the starting 2.5 mg dose, this adjustment window applies — the purpose of that initial pen is to let your body acclimatise before any step-up is considered. Our page on when to increase your Mounjaro dose gives context on how and why the schedule is paced the way it is.

Seek medical attention promptly if you experience: a heart rate that is consistently very high (above 100 bpm at rest) and not explained by exertion or illness; palpitations accompanied by chest tightness, breathlessness or dizziness; or any fainting or near-fainting. These symptoms go beyond the small background effect seen in trials and need clinical assessment the same day, not a prescription renewal. Call 111 or see your GP; if symptoms are severe, call 999.

People with a pre-existing heart rhythm condition should have discussed Mounjaro's cardiac effects with their prescriber before starting. If that conversation didn't happen, now is the time to have it.

How this fits into dose decisions going forward

An elevated heart rate that persists, or that worsens at each dose increase, is clinically relevant information for your prescriber. It may influence whether your next step-up goes ahead on schedule, is delayed, or (in rare cases) whether a different treatment approach is considered. That is precisely the kind of conversation a prescriber weighs up; it is not a decision you should make by adjusting your dose yourself.

If you are thinking about a dose change anyway, the pages on why doses are increased and how dose increases work set out the clinical rationale clearly. And if you are comparing tirzepatide with other treatment options, our weight-loss treatment overview gives a broader view.

One practical note: if your review is due around a bank holiday or a month where you ordered later than usual, the timing gap can feel longer. Mounjaro is available for same-day dispatch at the current treatment price when ordered by midday on a weekday, but any dose change still needs a prescriber's sign-off first, regardless of when the order lands.

Some people also notice other unexpected changes during treatment. An increase in libido, for instance, has been reported anecdotally and is discussed on our page about Mounjaro and libido changes for those curious about that side of the picture.

If you have unresolved questions or want your heart-rate pattern reviewed by a clinician who knows your history, our team is available seven days a week. Speak to our prescribers through a free consultation, a real clinician reads every submission, not an automated system.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions